Hollywood’s underbelly just got uglier with the revelation that Jasveen Sangha, infamously dubbed the “Ketamine Queen,” has pleaded guilty to supplying the drugs that ended the life of beloved “Friends” star Matthew Perry.
According to New York Post, in a case that has shocked fans and exposed the dark side of celebrity access to dangerous substances, Sangha admitted to five federal charges tied to ketamine distribution, including the dose that killed Perry in October 2023.
Perry, who charmed millions as Chandler Bing, was only 54 when he was found lifeless in his Los Angeles home, with the medical examiner pointing to ketamine as the primary cause of his tragic end.
Let’s rewind to the events leading up to this grim outcome, where Perry, battling depression, had been using ketamine legally under a doctor’s care but craved more than what was prescribed.
That desperate search led him, through a friend named Erik Fleming, to Sangha— a 42-year-old dual citizen of the U.S. and U.K.—just two weeks before his death.
Sangha, who flaunted a jet-setting lifestyle on social media while quietly catering to high-end clients, didn’t hesitate to cash in on Perry’s vulnerability, selling him 25 vials of the drug for $6,000 just days before he passed.
On the very day Perry died, Sangha allegedly told Fleming to erase all traces of their communications, a move straight out of a crime thriller but sadly all too real, according to her indictment.
Fleming himself messaged Perry’s assistant, hyping Sangha’s product as “amazing” for elite circles.
Well, “amazing” turned into deadly, didn’t it, when a sitcom legend’s life was snuffed out by a substance peddled to the rich and famous without a shred of regard for consequences?
Sangha’s guilty plea, finalized in August 2024, spared her a trial that was looming just a month later, and now she faces sentencing on December 10, 2024, with up to 65 years behind bars on the table.
Prosecutors may push for a lighter sentence under the plea deal, though the judge isn’t bound by their recommendation—a small comfort for those who see justice as needing a heavier hand for such reckless profiteering.
She’s not alone in this mess; Sangha is the last of five defendants to admit guilt in connection with Perry’s death, joining names like Dr. Salvador Plasencia, Dr. Mark Chavez, Kenneth Iwamasa, and Erik Fleming, all of whom cooperated with authorities.
Those co-defendants didn’t hold back, providing statements that pointed fingers squarely at Sangha and Plasencia for their roles in this tragedy, though none have faced sentencing yet.
This case isn’t just about one dealer or one death—it’s a glaring spotlight on how easily the powerful can exploit loopholes and addictions, all while progressive policies often seem to downplay the severity of drug trafficking in favor of so-called “harm reduction” narratives.
Perry’s story is a heartbreaking reminder that fame doesn’t shield anyone from the predatory undercurrents of a society too quick to normalize dangerous substances, and it’s high time we demand accountability over empty empathy from those who enable such loss.
